fashion -WSS

fashion

author：leisure time 2025-10-01 04:33:08 - browse：59126

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

hotspot

WSS

‘The Bear’ and hospitality in hospitals

Biden praises World Series champion Astros for impact off the field during White House celebration

To avoid data mishandling cases, universities eye AI and other tools

More regulation could be coming for drug ads

BioAge raises $170M for combination therapy with Zepbound

Astronauts get first look at the spacecraft that will fly them around the moon

hotspot

fashion

Sign up for D.C. Diagnosis

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biden report: The neurospychology of memory and aging

DIEP, the 'gold standard' of breast reconstruction, is under threat

More regulation could be coming for drug ads

At least 13 dead in Texas as scorching temps continue

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Heart attack and stroke risk calculators need revising

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Psychedelics group wrestles with new pharma identity

Biden report: The neurospychology of memory and aging

knowledge

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

Gilead might be held responsible for not developing a drug

Industry veterans launch new biotech VC with $310M

What should King Charles tell the public about his cancer?

What we’ve learned from the Aduhelm mess

What we’ve learned from the Aduhelm mess

hotspot

entertainment

knowledge

hotspot